Direct‐acting antivirals withdrawn from the market vs control
Proportion of participants with one or more serious adverse event at maximum · adults with chronic hepatitis C
It is very uncertain whether direct‐acting antivirals withdrawn from the market changes proportion of participants with one or more serious adverse event at… compared with control (very low certainty).
1 finding from 1 review
- OR 1.45 [1.22, 1.73]29 studies · 9229 participantsVery low